Gatidis, Sergios Dept. Empirical Inference, Max Planck Institute for Intelligent Systems, Max Planck Society; External Organizations;
https://doi.org/10.3390/cancers16152669 (Publisher version)
https://europepmc.org/article/MED/39123397 (Postprint)
https://doi.org/10.3390/cancers17010001 (Supplementary material)
Peisen, F., Gerken, A., Hering, A., Dahm, I., Nikolaou, K., Gatidis, S., et al. (2026). Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors? Cancers / Molecular Diversity Preservation International (MDPI), 16(15): 2669. doi:10.3390/cancers16152669.